Press Releases - 2021-08-17
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
Press Releases - 2021-08-13
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
Press Releases - 2021-08-11
Celea Therapeutics – Deupirfenidone (LYT-100)
PureTech Announces that Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome
Press Releases - 2021-07-22
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children with ADHD